LikeMinds is a Boston-based dopamine transporter (DAT) imaging company. The LikeMinds team previously developed Neupro®, the world’s first transdermal movement disorder drug for Parkinson’s and Restless Legs Syndrome. LikeMinds has assembled a globally recognized board of directors, board of advisors and strategic collaborators.
Utilizing proprietary DAT imaging and machine learning, LikeMinds will revolutionize the way doctors and pharmaceutical companies predict, diagnose, monitor and treat dopamine-related diseases.
Someday, doctors will detect dopamine-mediated diseases years before the first symptoms, thereby enabling early medical intervention. Our mission is to help make someday happen sooner.
Company Details
- Employees
- 10
- Founded
- -
- Address
- 359 Newbury St, Boston,massachusetts,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.LikeMinds.com
- Keywords
- DATimaging.
- HQ
- Boston, Massachusetts
Likeminds Questions
Likeminds's website is http://www.LikeMinds.com
Likeminds's LinkedIn profile is https://www.linkedin.com/company/likemindsboston
Likeminds has
10 employees.
View email and phone details for 10
employees at Likeminds.
Likeminds's industry is
Biotechnology Research
Likeminds's top competitors are
Cognos Therapeutics Inc,
Gravl,
Agp Ventures Lp,
Bansen Labs,
More Human,
Piper Sandler,
1bio,
Breathe Biomedical Inc.,
8percent Growth,
Likeminds.
Likeminds's categories are Biotechnology Research
Likeminds's founding year is 2016
